Loop mediated isothermal amplification (LAMP) for the detection and subtyping of human papillomaviruses (HPV) in oropharyngeal squamous cell carcinoma (OPSCC)

Journal of Clinical Virology

Volumn 75, Issue , 2016, Pages 37-41

  Livingstone, D M ^a   Rohatensky, M ^b   Mintchev, P ^a   Nakoneshny, S C ^a   Demetrick, D J ^c   van Marle, G ^a   Dort, J C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

Author keywords

HPV; LAMP; Loop mediated isothermal amplification; OPSCC; Oropharynx

Indexed keywords

CARCINOMA, SQUAMOUS CELL; CLASSIFICATION; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; ISOLATION AND PURIFICATION; NUCLEIC ACID AMPLIFICATION; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PROCEDURES; SENSITIVITY AND SPECIFICITY; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 31; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; SENSITIVITY AND SPECIFICITY;

EID: 84955447923     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2016.01.002     Document Type: Article

References (32)

1. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 2011, 29(32):4294-4301.
2. Chaturvedi A.K., Engels E.A., Anderson W.F., Gillison M.L. Incidence trends for human papillomavirus-related and-unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 2008, 26(4):612-619.
3. Blomberg M., Nielsen A., Munk C., Kjaer S.K. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. Int. J. Cancer 2011, 129(3):733-741.
4. Kreimer A.R., Clifford G.M., Boyle P., Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 2005, 14(2):467-475.
5. Jung A.C., Briolat J., Millon R., et al. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int. J. Cancer 2010, 126(8):1882-1894.
6. Ang K.K., Harris J., Wheeler R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 2010, 363(1):24-35.
7. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl. Cancer Inst. 2008, 100(4):261-269.
8. Posner M.R., Lorch J.H., Goloubeva O., et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann. Oncol. 2011, 22(5):1071-1077.
9. Forastiere A.A. Chemotherapy in the treatment of locally advanced head and neck cancer. J. Surg. Oncol. 2008, 97(8):701-707.
10. Mirghani H., Amen F., Blanchard P., et al. Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Int. J. Cancer 2015, 136(7):1494-1503.
11. Semrau R., Duerbaum H., Temming S., et al. Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer. Head Neck 2013, 35(9):1339-1344.
12. Panwar A., Batra R., Lydiatt W.M., Ganti A.K. Human papilloma virus positive oropharyngeal squamous cell carcinoma: a growing epidemic. Cancer Treat Rev. 2014, 40(2):215-219.
13. Robinson M., Schache A., Sloan P., Thavaraj S. HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients. Head Neck Pathol. 2012, 6(Suppl. 1):S83-90.
14. Schache A.G., Liloglou T., Risk J.M., et al. Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. Br. J. Cancer 2013, 108(6):1332-1339.
15. Rischin D., Young R.J., Fisher R., et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J. Clin. Oncol. 2010, 28(27):4142-4148.
16. Schlecht N.F., Brandwein-Gensler M., Nuovo G.J., et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod. Pathol. 2011, 24(10):1295-1305.
17. Stevens T.M., Caughron S.K., Dunn S.T., Knezetic J., Gatalica Z. Detection of high-risk HPV in head and neck squamous cell carcinomas: comparison of chromogenic in situ hybridization and a reverse line blot method. Appl. Immunohistochem. Mol. Morphol. 2011, 19(6):574-578.
18. Klussmann J.P., Gultekin E., Weissenborn S.J., et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am. J. Pathol. 2003, 162(3):747-753.
19. Notomi T., Okayama H., Masubuchi H., et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000, 28(12):E63.
20. Tomita N., Mori Y., Kanda H., Notomi T. Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products. Nat. Protoc. 2008, 3(5):877-882.
21. Poon L.L., Wong B.W., Ma E.H., et al. Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin. Chem. 2006, 52(2):303-306.
22. Iwamoto T., Sonobe T., Hayashi K. Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, Mavium, and M. intracellulare in sputum samples. J. Clin. Microbiol. 2003, 41(6):2616-2622.
23. Paris D.H., Imwong M., Faiz A.M., et al. Loop-mediated isothermal PCR (LAMP) for the diagnosis of falciparum malaria. Am. J. Trop. Med. Hyg. 2007, 77(5):972-976.
24. Hagiwara M., Sasaki H., Matsuo K., Honda M., Kawase M., Nakagawa H. Loop-mediated isothermal amplification method for detection of human papillomavirus type 6, 11, 16, and 18. J. Med. Virol. 2007, 79(5):605-615.
25. Kabeya M., Furuta R., Kawabata K., Takahashi S., Ishikawa Y. Prevalence of human papillomavirus in mobile tongue cancer with particular reference to young patients. Cancer Sci. 2012, 103(2):161-168.
26. Prakrankamanant P., Leelayuwat C., Promptmas C., et al. The development of DNA-based quartz crystal microbalance integrated with isothermal DNA amplification system for human papillomavirus type 58 detection. Biosens. Bioelectron. 2013, 40(1):252-257.
27. Karlsen F., Kalantari M., Jenkins A., et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J. Clin. Microbiol. 1996, 34(9):2095-2100.
28. Saetiew C., Limpaiboon T., Jearanaikoon P., et al. Rapid detection of the most common high-risk human papillomaviruses by loop-mediated isothermal amplification. J. Virol. Methods 2011, 178(1-2):22-30.
29. Rohatensky M.L.D. Mintchev P. van Marle G. Demetrick D., Dort J Developing Loop Mediated Isothermal Amplification (LAMP) for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) In: Presented at Alberta Society of Otolaryngology Meeting University of Calgary; 2015.
30. Mannarini L., Kratochvil V., Calabrese L., et al. Human papilloma virus (HPV) in head and neck region: review of literature. Acta Otorhinolaryngol. Ital. 2009, 29(3):119-126.
31. Nimesh M., Joon D., Varma-Basil M., Saluja D. Development and clinical evaluation of sdaA loop-mediated isothermal amplification assay for detection of Mycobacterium tuberculosis with an approach to prevent carryover contamination. J. Clin. Microbiol. 2014, 52(7):2662-2664.
32. Swan D.C., Tucker R.A., Tortolero-Luna G., et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 1999, 37(4):1030-1034.